Literature DB >> 22614872

Modafinil improves performance in the multiple T-Maze and modifies GluR1, GluR2, D2 and NR1 receptor complex levels in the C57BL/6J mouse.

Sunetra Sase1, Deeba Khan, Fernando Sialana, Harald Höger, Nina Russo-Schlaff, Gert Lubec.   

Abstract

Modafinil has been shown to modify behavioural and cognitive functions and to effect several brain receptors. Effects, however, were not observed at the receptor protein complex level and it was therefore the aim of the study to train mice in the multiple T-Maze (MTM) as a paradigm for spatial memory and to determine paralleling brain receptor complex levels. Sixty C57BL/6J mice were used in the study and divided into four groups (trained drug injected; trained vehicle injected; yoked drug injected; yoked vehicle injected). Animals obtained training for 4 days and were killed 6 h following the last training session on day 4. Hippocampi were dissected from the brain, membrane fractions were prepared by ultracentrifugation and were run on blue-native gels and immunoblotted with antibodies against major brain receptors. Modafinil treatment led to decreased latency and increased average speed, but not to changes in pathlength and number of correct decisions in the MTM. Drug effects were modifying receptor complexes of GluR1, GluR2, D2 and NR1. Training effects on receptor complex levels were observed for GluR3, D1 and nicotinic acetylcholine receptor alpha 7 (Nic7). GluR1 levels were correlating with GluR2 and D1 levels were correlating with D2 and NR1. Involvement of the glutamatergic, NMDA, dopaminergic and nicotinergic system in modafinil and memory training were herein described for the first time. A brain receptor complex pattern was revealed showing the concerted action following modafinil treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22614872     DOI: 10.1007/s00726-012-1306-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  6 in total

1.  Conformational transitions in the glycine-bound GluN1 NMDA receptor LBD via single-molecule FRET.

Authors:  David R Cooper; Drew M Dolino; Henriette Jaurich; Bo Shuang; Swarna Ramaswamy; Caitlin E Nurik; Jixin Chen; Vasanthi Jayaraman; Christy F Landes
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

2.  Modafinil restores methamphetamine induced object-in-place memory deficits in rats independent of glutamate N-methyl-D-aspartate receptor expression.

Authors:  Carmela M Reichel; Meghin G Gilstrap; Lauren A Ramsey; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

3.  A novel familial 9q31.2q32 microdeletion: Muscle cramping, somnolence, fatigue, sensorineural hearing loss, pubertal delay, and short stature.

Authors:  Anand K Ramineni; Trent Burgess; Penny Cruickshanks; David Coman
Journal:  Clin Case Rep       Date:  2019-01-07

4.  Differential effects of wake promoting drug modafinil in aversive learning paradigms.

Authors:  Bharanidharan Shanmugasundaram; Volker Korz; Markus Fendt; Katharina Braun; Gert Lubec
Journal:  Front Behav Neurosci       Date:  2015-08-19       Impact factor: 3.558

5.  The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze.

Authors:  Yasemin Karabacak; Sunetra Sase; Yogesh D Aher; Ajinkya Sase; Sivaprakasam R Saroja; Ana Cicvaric; Harald Höger; Michael Berger; Vasiliy Bakulev; Harald H Sitte; Johann Leban; Francisco J Monje; Gert Lubec
Journal:  Front Behav Neurosci       Date:  2015-08-19       Impact factor: 3.558

6.  A Novel Heterocyclic Compound CE-104 Enhances Spatial Working Memory in the Radial Arm Maze in Rats and Modulates the Dopaminergic System.

Authors:  Yogesh D Aher; Saraswathi Subramaniyan; Bharanidharan Shanmugasundaram; Ajinkya Sase; Sivaprakasam R Saroja; Marion Holy; Harald Höger; Tetyana Beryozkina; Harald H Sitte; Johann J Leban; Gert Lubec
Journal:  Front Behav Neurosci       Date:  2016-02-22       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.